Kim, Sung Hye
Riaposova, Lucia
Ahmed, Hauwa
Pohl, Oliver
Chollet, André
Gotteland, Jean-Pierre
Hanyaloglu, Aylin http://orcid.org/0000-0003-4206-737X
Bennett, Phillip R.
Terzidou, Vasso http://orcid.org/0000-0002-7579-4947
Funding for this research was provided by:
DH | National Institute for Health Research (P45272, P45272)
Genesis Research Trust
Article History
Received: 22 November 2018
Accepted: 19 March 2019
First Online: 8 April 2019
Competing Interests
: V.T. has worked as a consultant to GlaxoSmithKline. P.B. has worked as a consultant to Boehringer Ingelheim, GlaxoSmithKline, Merck Serono, ObsEva SA and Tokyo Tanabe Pharmaceuticals, drug companies with an interest in the pharmacological effects of oxytocin and oxytocin antagonists. P.B. holds shares of ObsEva SA. J.P.G. and O.P. are salaried employees of ObsEva SA. A.C. is a consultant to ObsEva SA.